Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.ajantapharma.com | |
Market Cap | 15,489.69 Cr. | |
Enterprise Value(EV) | 15,157.61 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 48.15 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | 25.10 | Trailing Twelve Months Ending 2022-12 |
Industry PE | 32.41 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 291.76 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 4.14 | Calculated using Price: 1,208.55 |
Dividend Yield | 0.52 | Period Ending 2022-03 |
No. of Shares Subscribed | 12.81 Cr. | 128,125,155 Shares |
FaceValue | 2 | |
Company Profile | ||
Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages. Its business includes Branded Generics in emerging markets of Asia and Africa, Generics in the developed markets of USA and Institution sales. Emerging markets are the major contributors in company's branded generic business where it is present across Asia and Africa. It has designed customised basket of products for each of these markets and serve wide range of therapeutic segments like Anti-Biotic, Anti-Malarial, Anti-Diabetic, Cardiology, Gynecology, Orthopedics, Pediatric, Respiratory & General Health products. |
1 Day |
|
+0.28% |
1 Week |
|
+2.24% |
1 Month |
|
+2.57% |
3 Month |
|
-0.17% |
6 Month |
|
-4.05% |
1 Year |
|
+0.20% |
2 Year |
|
+1.09% |
5 Year |
|
+28.95% |
10 Year |
|
+956.61% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 47.47 | 43.24 | 40.93 | 36.77 | 26.00 | 18.07 | 19.32 | 23.38 | 22.77 | |
Return on Capital Employed (%) | 54.52 | 56.43 | 51.59 | 45.72 | 34.49 | 23.84 | 27.44 | 32.20 | 29.37 | |
Return on Assets (%) | 28.05 | 29.57 | 31.66 | 30.69 | 22.06 | 14.52 | 14.44 | 17.03 | 16.79 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 593 | 841 | 1,191 | 1,568 | 2,041 | 2,245 | 2,599 | 2,996 | 3,264 | 3,603 | |
Non Curr. Liab. | 81 | 56 | 29 | 9 | 39 | 162 | 228 | 275 | 279 | 65 | |
Curr. Liab. | 275 | 250 | 260 | 247 | 346 | 498 | 746 | 839 | 838 | 705 | |
Minority Int. | |||||||||||
Equity & Liab. | 949 | 1,146 | 1,479 | 1,823 | 2,426 | 2,906 | 3,572 | 4,109 | 4,381 | 4,373 | |
Non Curr. Assets | 429 | 513 | 716 | 973 | 1,202 | 1,605 | 1,791 | 1,891 | 1,926 | 1,725 | |
Curr. Assets | 520 | 633 | 763 | 851 | 1,224 | 1,301 | 1,781 | 2,218 | 2,455 | 2,649 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 949 | 1,146 | 1,479 | 1,823 | 2,426 | 2,906 | 3,572 | 4,109 | 4,381 | 4,373 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | 1,208 | 1,474 | 1,734 | 1,983 | 2,126 | 2,055 | 2,588 | 2,890 | 3,341 | 3,731 | |
Other Income | 14 | 17 | 21 | 24 | 24 | 21 | 92 | 26 | 116 | 138 | |
Total Income | 1,222 | 1,490 | 1,755 | 2,007 | 2,150 | 2,076 | 2,680 | 2,916 | 3,457 | 3,869 | |
Total Expenditure | -840 | -968 | -1,147 | -1,296 | -1,467 | -1,489 | -1,905 | -1,891 | -2,412 | -2,937 | |
PBIDT | 382 | 522 | 608 | 711 | 683 | 588 | 776 | 1,025 | 1,045 | 932 | |
Interest | -9 | -6 | -5 | -1 | 0 | -1 | -12 | -8 | -10 | -12 | |
Depreciation | -44 | -52 | -44 | -61 | -60 | -72 | -96 | -116 | -125 | -129 | |
Taxation | -96 | -146 | -143 | -141 | -154 | -127 | -196 | -246 | -197 | -174 | |
Exceptional Items | -8 | -4 | |||||||||
PAT | 234 | 310 | 416 | 507 | 469 | 387 | 468 | 654 | 713 | 617 | |
Minority Interest | |||||||||||
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 234 | 310 | 416 | 507 | 469 | 387 | 468 | 654 | 713 | 617 | |
Adjusted EPS | 18 | 23 | 31 | 38 | 36 | 30 | 36 | 50 | 56 | 48 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 234 | 212 | 279 | 326 | 609 | 281 | 375 | 457 | 576 | 562 | |
Cash Fr. Inv. | -104 | -188 | -158 | -209 | -383 | -256 | -223 | -224 | -282 | -74 | |
Cash Fr. Finan. | -104 | -20 | -105 | -117 | -202 | 0 | -147 | -129 | -318 | -460 | |
Net Change | 26 | 4 | 16 | 0 | 24 | 25 | 4 | 104 | -24 | 28 | |
Cash & Cash Eqvt | 34 | 39 | 54 | 41 | 66 | 91 | 95 | 199 | 178 | 205 |
Fri, 31 Mar 2023
Closure of Trading Window Pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 as amended from time to time and Ajantas Code of Conduct for Insiders the Trading Window for dealing in securities of the Company shall remain closed for Designated Persons (as defined in the Code) from close of business hours of Friday 31st March 2023 till 48 hours after the declaration of Financial Results of the Company for the quarter and year ended 31st March 2023. |
Tue, 28 Mar 2023
Submission Of Letter Of Offer With reference to the captioned Buyback and in furtherance of our earlier intimation regarding submission of Public Announcement dated March 13 2023 published on March 14 2023 please find enclosed the Letter of Offer dated March 28 2023 along with the Tender Forms for demat and physical shareholders which are being dispatched by the Company to the Eligible Shareholders within two working days from the Record Date being March 24 2023. |
Tue, 14 Mar 2023
Announcement under Regulation 30 (LODR)-Public Announcement-Buyback of Shares This is in furtherance to our intimation dated March 10 2023 informing the stock exchanges w.r.t. Buy-back of 22 10 500 shares of the Company at a price of ? 1 425/- per equity share on a proportionate basis through the tender offer process (Buyback) in accordance with the provisions of the Companies Act 2013 and rules made thereunder and theSecurities and Exchange Board of India (Buy-Back of Securities) Regulations 2018 (the SEBI Buyback Regulations) as amended from time to time and other applicable laws.In this regard please find enclosed:(a) A copy of the Public Announcement as published in newspapers; and(b) Certified true copy of the resolution passed by the Board of Directors on dated March 10 2023 for approving the proposal of Buyback.You are requested to kindly take the same on record. |
Fri, 31 Mar 2023 |
|
|
|
|
|